Hepatitis C
What research knows about hepatitis C comes from people who live with it. Here is how many do, what records they usually have, and what sharing yours is worth.
What patients usually have
The records behind hepatitis C
Direct-acting antiviral course (glecaprevir/pibrentasvir or sofosbuvir/velpatasvir)
one course of 8 or 12 weeks
guidelineLiver ultrasound surveillance for liver cancer after treatment, in cirrhosis
every 6 months after treatment completion
guidelineQuantitative HCV RNA (with HIV and HBsAg tests) before treatment
once, before treatment
guidelineHCV RNA and aminotransferase test to confirm cure (SVR)
once, 12 or more weeks after treatment ends
guideline
What sharing it is worth
$93
per licence for a complete story and one year of these records, $93 to $1,170
- Your health story$23how
- Medication historyx1$2.33how
- Scan reportsx2$4.86how
- Lab resultsx2$0.42how
- Richness premium (4 kinds of data linked)x3how
A benchmark from published prices, not a promise: contributors earn a share each time a licence includes their data. How the benchmark works · What health data sells for